HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   Inflammatory Breast Cancer (https://her2support.org/vbulletin/forumdisplay.php?f=42)
-   -   another spanking new IBC article (https://her2support.org/vbulletin/showthread.php?t=41118)

Lani 09-17-2009 06:57 AM

another spanking new IBC article
 
Cell Cycle. 2009 Oct 23;8(19). [Epub ahead of print]

Inflammatory breast cancer cells are constitutively adapted to hypoxia.

Silvera D, Schneider RJ.
Department of Microbiology, New York University School of Medicine, New York, NY, USA.
We recently showed that overexpression of translation initiation factor eIF4G partially drives the unusual pathological features of Inflammatory Breast Cancer (IBC),(16) the most lethal form of primary breast cancer.(7) IBC has the peculiar feature that, rather than develop as a solid tumor, it typically generates rapidly metastasizing tight clusters of cancer cells referred to as tumor cell emboli, consisting of cancer cells held together by increased membrane expression of E-cadherin. Overexpression of eIF4GI in IBC leads to a specific increase in the translation of internal ribosomal entry site (IRES) containing mRNAs, of which two encode key proteins involved in the pathological features of IBC. One of these mRNAs encodes p120 catenin, which mediates E-cadherin retention at the cell surface, and the other encodes VEGF, which accounts for high levels of IBC angiogenesis and resistance to hypoxia. Here we show that IBC cells have adapted to the persistent hypoxia they experience as tumor emboli, by reprogramming the protein synthesis machinery to constitutively translate mRNAs required for IBC cell survival during hypoxia, even under normal oxygen (normoxic) conditions. Thus, IBC cells have been able to behave as if they are continuously hypoxic even when they are not.
PMID: 19755858 [PubMed - as supplied by publisher]


All times are GMT -7. The time now is 03:33 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021